These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7523319)

  • 1. Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes.
    Trisler K; Specter S
    Int J Immunopharmacol; 1994 Jul; 16(7):593-603. PubMed ID: 7523319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity.
    Kawakami Y; Klein TW; Newton C; Djeu JY; Specter S; Friedman H
    Int J Immunopharmacol; 1988; 10(4):485-8. PubMed ID: 2844686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of natural killer but not natural cytotoxic activity in a cloned cell line by delta-9-tetrahydrocannabinol.
    Wang M; Richards AL; Friedman H; Djeu JY
    J Leukoc Biol; 1991 Aug; 50(2):192-7. PubMed ID: 1649242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana effects on immunity: suppression of human natural killer cell activity of delta-9-tetrahydrocannabinol.
    Specter SC; Klein TW; Newton C; Mondragon M; Widen R; Friedman H
    Int J Immunopharmacol; 1986; 8(7):741-5. PubMed ID: 3023245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. delta-9-Tetrahydrocannabinol (THC) decreases the number of high and intermediate affinity IL-2 receptors of the IL-2 dependent cell line NKB61A2.
    Zhu W; Igarashi T; Qi ZT; Newton C; Widen RE; Friedman H; Klein TW
    Int J Immunopharmacol; 1993 Apr; 15(3):401-8. PubMed ID: 8389328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo.
    Klein TW; Kawakami Y; Newton C; Friedman H
    J Toxicol Environ Health; 1991 Apr; 32(4):465-77. PubMed ID: 1850002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of lymphocyte adenosine 3':5'-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol.
    Diaz S; Specter S; Coffey RG
    Int J Immunopharmacol; 1993 May; 15(4):523-32. PubMed ID: 8396073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential suppression of T-cell subpopulations by thc (delta-9-tetrahydrocannabinol).
    Pross SH; Klein TW; Newton CA; Smith J; Widen R; Friedman H
    Int J Immunopharmacol; 1990; 12(5):539-44. PubMed ID: 2170281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marijuana and immunity: tetrahydrocannabinol mediated inhibition of lymphocyte blastogenesis.
    Specter S; Lancz G; Hazelden J
    Int J Immunopharmacol; 1990; 12(3):261-7. PubMed ID: 2158486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of interleukin 2 activity by delta 9-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody.
    Nakano Y; Pross SH; Friedman H
    Proc Soc Exp Biol Med; 1992 Nov; 201(2):165-8. PubMed ID: 1329110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human macrophage function in vitro by delta 9-tetrahydrocannabinol.
    Specter S; Lancz G; Goodfellow D
    J Leukoc Biol; 1991 Nov; 50(5):423-6. PubMed ID: 1660911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of aging and cytokines to the immunomodulation by delta-9-tetrahydrocannabinol on murine lymphoid cells.
    Snella E; Pross S; Friedman H
    Int J Immunopharmacol; 1995 Dec; 17(12):1045-54. PubMed ID: 8964654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol.
    Bhargava HN; House RV; Thorat SN; Thomas PT
    Pharmacology; 1996 May; 52(5):271-82. PubMed ID: 8807671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta 9-tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells.
    Fischer-Stenger K; Updegrove AW; Cabral GA
    Proc Soc Exp Biol Med; 1992 Jul; 200(3):422-30. PubMed ID: 1319584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and reversal of delta-9-tetrahydrocannabinol induced depression of natural killer cell activity by interleukin-2.
    Specter S; Rivenbark M; Newton C; Kawakami Y; Lancz G
    Int J Immunopharmacol; 1989; 11(1):63-9. PubMed ID: 2540100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression by cannabinoids of a cloned cell line with natural killer cell activity.
    Kawakami Y; Klein TW; Newton C; Djeu JY; Dennert G; Specter S; Friedman H
    Proc Soc Exp Biol Med; 1988 Mar; 187(3):355-9. PubMed ID: 2831542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes.
    Kusher DI; Dawson LO; Taylor AC; Djeu JY
    Cell Immunol; 1994 Mar; 154(1):99-108. PubMed ID: 8118892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effect of delta-9-tetrahydrocannabinol on IL-2 activity in spleen and lymph node cells of mice of different ages.
    Nakano Y; Pross S; Friedman H
    Life Sci; 1993; 52(1):41-51. PubMed ID: 8380215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes.
    Chirigos MA; Talor E; Sidwell RW; Burger RA; Warren RP
    Immunopharmacol Immunotoxicol; 1995 May; 17(2):247-64. PubMed ID: 7650289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.